Why the study?
Heart failure mortality is high in sub-Saharan Africa, but few studies have reported long-term predictors of mortality in this region.
Cohort (n=347)
Yes
Hazard Ratio: 2.23 (95% CI 1.49–3.33)
p-value: p=<0.001
In a Sub-Saharan African cohort, nearly half of heart failure patients died within 3 years, with late presentation and poverty-related conditions strongly predicting mortality.
Background: Heart failure (HF) is a growing public health concern with a high mortality rate in sub-Saharan Africa. However, few studies have reported the long-term predictors of mortality in this region. This study sought to determine the 3-year mortality rate and the predictors of mortality amongst HF patients in Douala, Cameroon. Methods: We conducted a prospective analysis on patients recruited in the Douala Heart Failure (Do-HF) registry, an ongoing prospective data collection on patients with HF at four cardiology units in Douala, Cameroon. Patients included were followed for 36 months from the index date of inclusion, with all-cause mortality as the primary outcome. Cox proportional hazard regression models were used to determine predictors of mortality. Results: Out of the 347 participants included, 318 (91.6%) completed follow-up. The mean age was 64±14 years, 172 (49.6%) were men. Hypertensive cardiomyopathy and dilated cardiomyopathy were the most frequent causes of heart failure. The median follow-up was 33 months, and 150 (47.2%) patients died. Independent predictors of mortality included New York Heart Association functional class III & IV (aHR 2.23; 95% CI: 1.49-3.33; P<0.001), presence of pulmonary rales (aHR 1.87; 95% CI: 1.30-2.68; P=0.005), chronic kidney disease (aHR 2.92; 95% CI: 1.79-4.78; P<0.001), enrolment as inpatient (aHR1.96; 95% CI: 1.17-2.54; P=0.005), no formal education (aHR 2.06; 95% CI: 1.28-3.33; P=0.003), and a monthly income of at most three minimum wage (aHR 2.06; 95% CI: 1.28-3.33; P=0.003). Conclusions: This study shows that almost half of HF patients die after 36 months of follow-up. Also, late presentation and poverty-related conditions were associated with poor outcomes. These findings suggest prioritizing preventive strategies that target early diagnosis and socioeconomic status to improve the prognosis of HF.
No takes yet. Share an insight, caveat, or question.
Dzudié et al. (2022) conducted a cohort in Heart failure (n=347). NYHA functional class III & IV vs. NYHA functional class I & II was evaluated on All-cause mortality at 36 months (aHR 2.23, 95% CI 1.49-3.33, p=<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: